2000-2022年全球消除麻疹进展
本报告描述2000-2022年全球消除麻疹进展。2000-2019年全球MCV第一剂覆盖率从72%升至86%,2021年疫情期间降至81%,2022年回升至83%。2021-2022年估算麻疹病例增加18%,从7,802,000例增至9,232,300例;估算麻疹死亡增加43%,从95,000例增至136,200例。
要点
- 2022年全球MCV第一剂覆盖率回升至83%,但低收入国家覆盖率下降。
- 2021-2022年估算麻疹病例增加18%,发生大规模或破坏性暴发的国家从22个增至37个。
核心结论
- 2022年麻疹疫苗接种覆盖率和全球监测从COVID-19疫情挫折中有所恢复,但低收入国家覆盖率下降,全球多年免疫覆盖不理想使数百万儿童未受保护。
- 通过重新努力为所有儿童接种2剂MCV并加强监测,可扭转COVID-19疫情期间的覆盖率挫折,从而预防暴发并加速消除麻疹进展。
研究设计与样本
- 本报告描述2000-2022年全球消除麻疹进展,数据来源包括全球MCV覆盖率估算和麻疹病例报告。
主要发现
- 2000-2019年全球MCV第一剂估算覆盖率从72%升至86%,2021年COVID-19疫情期间降至81%,为2008年以来最低,2022年回升至83%。
- 2022年,144个报告麻疹病例的国家中仅一半(72个)达到每10万人口2例或以上 discarded cases 的麻疹监测指标目标。
- 2021-2022年估算麻疹病例增加18%,从7,802,000例增至9,232,300例;发生大规模或破坏性暴发的国家从22个增至37个。
- 2021-2022年估算麻疹死亡增加43%,从95,000例增至136,200例。
关键数值与推荐
- 2022年麻疹监测指标目标为每10万人口2例或以上 discarded cases,144个报告麻疹病例的国家中72个达到该目标。
临床怎么用
- 作者建议重新努力为所有儿童接种2剂MCV并加强监测,以预防暴发并加速消除麻疹进展。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Measles is a highly contagious, vaccine-preventable disease that requires high population immunity for transmission to be interrupted. All six World Health Organization regions have committed to eliminating measles; however, no region has achieved and sustained measles elimination. This report describes measles elimination progress during 2000-2022. During 2000-2019, estimated coverage worldwide with the first dose of measles-containing vaccine (MCV) increased from 72% to 86%, then declined to 81% in 2021 during the COVID-19 pandemic, representing the lowest coverage since 2008. In 2022, first-dose MCV coverage increased to 83%. Only one half (72) of 144 countries reporting measles cases achieved the measles surveillance indicator target of two or more discarded cases per 100,000 population in 2022. During 2021-2022, estimated measles cases increased 18%, from 7,802,000 to 9,232,300, and the number of countries experiencing large or disruptive outbreaks increased from 22 to 37. Estimated measles deaths increased 43% during 2021-2022, from 95,000 to 136,200. Nonetheless, an estimated 57 million measles deaths were averted by vaccination during 2000-2022. In 2022, measles vaccination coverage and global surveillance showed some recovery from the COVID-19 pandemic setbacks; however, coverage declined in low-income countries, and globally, years of suboptimal immunization coverage left millions of children unprotected. Urgent reversal of coverage setbacks experienced during the COVID-19 pandemic can be accomplished by renewing efforts to vaccinate all children with 2 MCV doses and strengthening surveillance, thereby preventing outbreaks and accelerating progress toward measles elimination.
引用
- Minta AA, Ferrari M, Antoni S, et al. Progress Toward Measles Elimination - Worldwide, 2000-2022. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37971951. doi:10.15585/mmwr.mm7246a3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。